Investor Profile: TVM Capital Healthcare — Thesis, Cheque Size & How to Apply

Founders and operators tracking TVM Capital Healthcare funding should know this is growth equity, not seed VC: an emerging-markets healthcare private-equity investor and operator providing growth capital to companies expanding access to quality healthcare. Headquartered in Dubai and Singapore with offices in Riyadh, Boston, Munich and Ho Chi Minh City, the firm combines financial returns with measurable ESG impact and has been a UN PRI signatory since 2015.

Thesis and focus

TVM Capital Healthcare leads growth investments in specialised healthcare services, tech-enabled healthcare services, digital-health solutions and platforms, pharmaceutical manufacturing, medical devices and diagnostics — backing regional sector champions through an operator-led model across Southeast Asia and MENA. Its Afiyah Fund closed oversubscribed at approximately US$254 million in 2024, and its Southeast Asia Fund reached first close in September 2025.

Stages, cheque size and track record

The firm invests expansion and growth capital as a lead investor; cheque sizes and firm-level AUM are not publicly disclosed. The track record is concrete: it exited the Cambridge Medical & Rehabilitation Center for US$232 million, a 4.6x return on capital invested.

Notable portfolio

Verified portfolio companies include Baraya Extended Care, DEBx Medical, neurocare, Human Longevity, Inc., MeJa Psychologie, IV ONE Health, ProVita International Medical Center, Manzil Healthcare Services and Bourn Hall International — the last of which has India operations, giving the firm a real (if thin) India link.

Partners

Leadership includes Helmut M. Schühsler (Chairman & CEO), Farid Fezoua (Managing Partner), Youssef Haidar (Managing Director), Jad Halaby (Operating Partner, appointed February 2026) and Holly Radel (Head of Sustainability and Strategic Communications). The firm states it has been active in the Middle East since 2009 and in Southeast Asia since 2021.

How to apply for funding

There is no pitch portal — this is an institutional growth-equity firm whose investments are sourced as growth deals, not open applications. Founders of scaled healthcare businesses engage via the firm's website; the published press contact is [email protected]. This profile suits growth-stage healthcare operators, not pre-seed founders.

The firm's operator-led model is central to its pitch: it does not just fund healthcare companies but helps build regional champions, pairing capital with operating partners and a sustainability framework as a UN PRI signatory since 2015. Its Southeast Asia Fund reached first close in September 2025 with backing from Australian Development Investments, signalling continued deployment appetite across the region's healthcare markets.